Emerging data suggests yes. Recent reviews reveal that AI-generated drugs achieve Phase I success rates of 80-90% , compared ...
It’s not the tech that tanks AI projects — it’s the people and planning. The smartest companies are finally getting both ...
A decision every CEO faces when looking at AI adoption is whether to develop custom systems or deploy commercial ...